Latest Headlines

  1. Equipment Auction Announced For Sutro Biopharma Assets 11/24/2025

    December 15-16, 2025: Featuring late-model lab, R&D and manufacturing equipment surplus to future needs of Sutro BioPharma: spray dryer, chromatography systems, Westfalia seperators, HPLC’s & more.

  2. Henlius And Organon Announce US FDA Approval Of POHERDY (Pertuzumab-Dpzb), The First PERJETA (Pertuzumab) Biosimilar In The US 11/17/2025

    Shanghai Henlius Biotech, Inc., and Organon today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY (pertuzumab-dpzb) 420 mg/14 mL injection for intravenous use, an interchangeable biosimilar to PERJETA (pertuzumab), for all indications of the reference product.1

  3. Solid Biosciences Announces Licensing Agreement With Andelyn Biosciences For The Use Of Proprietary Next-Generation Capsid AAV-SLB101 11/17/2025

    Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a non-exclusive worldwide license and collaboration agreement with Andelyn Biosciences (Andelyn), a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), for the use of Solid’s proprietary, next-generation capsid, AAV-SLB101.

  4. AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth 11/11/2025

    AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.

  5. Abzena And Mabqi Announce Strategic Partnership To Offer Integrated Discovery Through Development Solution 11/6/2025

    This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution.

  6. Bora Pharmaceuticals Wins Biotech Company Of The Year Award 11/6/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of the Biotech Breakthrough Awards’ Overall Biotech Company of the Year award. The honor recognized Bora’s recent growth and its unique ability to provide the hands-on reliability of a dedicated partner with the infrastructure and scale of a global leader.

  7. Simtra BioPharma Solutions Expands Global Manufacturing Footprint To Advance The Future Of Sterile Injectables 10/27/2025

    In the United States at its site in Bloomington, Indiana, Simtra has added a flexible clinical line for prefilled syringes and liquid and lyophilized vials and is building a new production facility that will house three isolator commercial-scale sterile filling lines.

  8. Bora Pharmaceuticals Leverages State-Of-The-Art Isolator Production Line To Scale Supply Of Vital Oncology Therapy 10/23/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, will leverage its Groninger FlexPro 50 Isolator Line for Vials & Pre-filled Syringes to continue to broaden patients’ access to lifesaving treatments and therapies.

  9. BIOCHINA2026 – Fusion Forward: Uniting The Global Biopharma Community In Suzhou 10/20/2025
  10. MilliporeSigma Introduces Comprehensive AAV Express Platform For Streamlined Gene Therapy Production 10/17/2025